Skip to main content


Brisbane, Australia

23 - 26 Jul 2023

The 12th IAS Conference on HIV Science

IAS 2023, the 12th IAS Conference on HIV Science, will take place in Brisbane, Australia, and virtually from 23 to 26 July 2023. IAS 2023, being held at the Brisbane Convention and Exhibition Centre, will shine a spotlight on the world’s advances in HIV research.

View details View details
Scientist in a lab

20 Sep 2022

Building regulatory and ethics expertise for experimental medicine

This webinar will explore ways to improve the knowledge and capabilities of regulatory authorities to assess experimental medicine clinical research in high-income and low- and middle-income countries.

View details View details
Engaging adolescent girls and young women

6 Sep 2022

Engaging adolescent girls and young women in HIV prevention research – Unpacking the ethical dilemmas

The second in a two-part series, it will explore how we can leverage learnings from behavioural research to enhance better engagement of adolescent girls and young women in HIV programmes and research.

View details View details
Engaging adolescent girls and young women

30 Aug 2022

Engaging adolescent girls and young women in HIV prevention research – Unpacking the ethical dilemmas

The first in a two-part series, it will explore the need for engaging adolescent girls and young women in HIV research and help understand latest scientific developments and the ethical dilemmas.

View details View details
Montreal Canada

29 Jul - 2 Aug 2022

The 24th International AIDS Conference

For the first time, the world’s largest conference on HIV and AIDS will be hosted in person in Montreal, Canada, as well as virtually, to make it accessible to as many people as possible.

View details View details
African scientist, medical worker or tech in modern laboratory

28 Jul 2022

Pathways to an HIV cure: Research and advocacy priorities

IAS – the International AIDS Society – through its Towards an HIV Cure programme, organised the annual HIV cure meeting just before AIDS 2022, the 24th International AIDS Conference, as an Affiliated Independent Event. The hybrid meeting was organised in partnership with the Canadian HIV Cure Enterprise (CanCURE) and the FRQS - AIDS and Infectious Diseases Research Network. It took place in person at the Centre Hospitalier de l'Université de Montréal (CHUM) and virtually on 28 July 2022. The meeting programme was designed to reflect the “Research priorities for an HIV cure: IAS Global Scientific Strategy 2021”, published in Nature Medicine. The sessions highlighted cure advances globally and promising research strategies while translating the latest science and incorporating diverse perspectives on HIV cure. You can access all the meeting materials using the links below: Programme Recordings Presentations: Pathways to an HIV cure: Research and advocacy priorities - Welcome! IAS Global Scientific Strategy 2021 - Sharon Lewin, IAS & The Peter Doherty Institute for Infection and Immunity, Australia The science in context: a community perspective - Simon Collins, i-Base, UK Berlin, London, Dusseldorf and New York Patients - Kumitaa Theva Das, Universiti Sains Malaysia, Malaysia HIV Cure in the News: The South African child - Maria Paximadis, University of the Witwatersrand and National Institute for Communicable Diseases (Cell Biology), South Africa The San Francisco and Esperanza patients - Gabriela Turk, University of Buenos Aires, Argentina Exceptional HIV Elite Controllers - Javier Martinez-Picado, irsiCaixa AIDS Research Institute, Spain The Philadelphia patient - Pablo Tebas, University of Pennsylvania, USA amfAR-UCSF HIV Cure Trial - Michael Peluso, University of California, San Francisco, USA Considerations for cis-Women in HIV Cure Research - Jessica Prodger, Western University, Canada End of life research - Caroline Dufour, Université de Montréal, Canada The Last Gift Update - Jeff Taylor, University of California AntiViral Research Center, USA Virology of the reservoir - Zabrina Brumme, Simon Fraser University, Canada Broadly neutralizing antibodies and the HIV reservoir - Christian Gaebler, The Rockefeller University, USA Landscape analysis & diversifying efforts - Elizabeth Barr, National Institutes of Health, USA SHIV Reservoirs Persist Following CAR T Cell-Mediated Depletion of B Cell Follicles in Nonhuman Primates - Chris Peterson, Fred Hutch Cancer Center, USA Block, Lock, & Excise - Lishomwa Ndhlovu, Weill Cornell Medicine, USA HIV reactivation from latency using a Tat compound - Marion Pardons, Ghent University, Belgium The FRESH Cohort: 10 years of Acute HIV Research in South Africa - Krista Dong, iTeach, South Africa Sunnylands Retreat 2022: Ensuring Accessibility of Gene Therapy- Based Cures for HIV and Sickle Cell Disease - Sharon Lewin, IAS & The Peter Doherty Institute for Infection and Immunity, Australia

View details View details

27 Jul 2022

Getting to the Heart of Stigma Pre-conference

This pre-conference is a thought-leadership symposium seeking to present, discuss and interrogate the state-of-the-field evidence base for HIV-related stigma. It will be a platform to discuss global financial, strategic and programmatic efforts to contextualize, implement and scale up effective stigma reduction and mitigation interventions. The latest results from a global systematic review will be presented, alongside nuanced national case studies and examples of good practice, to situate the evidence base considering day-to-day realities for different communities in specific socio-cultural and policy contexts. The symposium will also feature discussions based on current policy guidelines, original global and country-level research, and political documents to guide progress on stigma reduction and mitigation around the world. Expert speakers and participants will come from the whole spectrum of health (for example, psychology and mental health, general practice, nursing and midwifery, and sexual and reproductive health), as well as other sectors, such as education and justice. The programme will be of interest to a diverse audience, including participants from a background in policy, research, community activism, funding and grant making, politics and healthcare and people living with HIV. Coupled with the thorough context-specific review of existing evidence, this multidisciplinary and multisectoral engagement will not only amplify and accelerate attention to stigma, but is intended to broaden expert discussions about effective programming, measurement and concepts relating to stigma in ways that catalyse lateral thinking and lead to improved interventions. The pre-conference will take place on Wednesday, 27 July. The programme is as follows: Session 1: Leadership, 09:00 – 10:00 The opening session celebrates the courageous individuals and interventions that effectively challenge stigma and seek redress for discrimination. This session aims to inspire greater leadership to address stigma at scale. Session 2: State of the field evidence review, 10:15 – 11:15 The latest findings from a global systematic evidence review and progress towards consensus to guide scaled-up practical action will be presented. The comments will be framed within the context of progress, focusing on interventions and practical implications of research. Session 3: Uniting for a common vision and acknowledging local realities, 11:30 – 12:30 This session will debate how best to move forward by better documenting processes, evaluating progress, measuring change over time and maximizing learning across disciplines so that the specific context can also inform a broader view. Session 4: Role of partnerships in funding comprehensive responses to stigma and discrimination, 14:00 – 15:00 The session will explore the resourcing barriers and opportunities for joining up to reduce stigma at scale, including coordination between financing processes and organizations to be informed by evidence and fund strategies that work. Session 5: Addressing stigma is not enough, 15:15 – 16:15 Looking forward, we know that addressing stigma alone is not enough and addressing HIV-related stigma (in isolation) is not enough. Frameworks and visions that seek to strengthen efforts to address stigma must resonate within the broader programmatic approaches and commitments to achieving the societal enablers targets and improving or informing programmes and advocacy. The final session will explore how the inclusion of commitments toward eliminating HIV-related stigma and discrimination within the Political Declaration agreed at the 2021 United Nations High-Level Meeting on HIV/AIDS for the first time also signals a conducive global political environment for action at scale. Sessions will be interactive and include expert presentations with the opportunity to engage in discussion for those participating in person or virtually, as well as some smaller group discussions. We are grateful to the organizing committee, which has put together a strong and interesting programme: Lucy Stackpool-Moore, IAS – International AIDS Society, Switzerland and Watipa, Australia Sbongile Nkosi, Global Network of People Living with HIV (GNP+), South Africa Alexandrina Iovita, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland Leickness Simbayi, Human Sciences Research Council (HSRC), South Africa Carmen Logie, Factor-Inwentash Faculty of Social Work, University of Toronto; Women’s College Research Institute, Women’s College Hospital and Centre for Gender and Sexual Health Equity, Canada Laura Waters, British HIV Association (BHIVA), UK Ani Shakarishvili, Joint United Nations Programme on HIV/AIDS (UNAIDS), Switzerland James Hargreaves, London School of Hygiene and Tropical Medicine (LSHTM), UK Pascal Macharia, Health Options for Young Men on HIV/AIDS/STI (HOYMAS, )Kenya Erika Castellanos, Global Action for Trans Equality (GATE), The Netherlands We hope that you can join us in Montreal or virtually and sign up to join the IAS Community of Practice for getting to the heart of stigma.

View details View details

1 Jun 2022 - 2 Jun 2022

Reflections on the COVID-19 pandemic and its application to the HIV response in West and Central Africa

IAS – the International AIDS Society – and APIN Public Health Initiatives are pleased to invite you to a regional scientific symposium, “Reflections on the COVID-19 pandemic and its application to the HIV response in West and Central Africa”. Speakers and participants will discuss the following key and pressing topics for the region: HIV and COVID-19: West and Central African success stories Innovations in HIV testing and diagnostics: The path forward to scaling up HIV treatment and care for key populations in West and Central Africa Achieving and sustaining viral load suppression in paediatric care: Challenges and opportunities The symposium will benefit clinicians, HIV service providers, researchers, policy makers, activists and people living with and affected by HIV. French interpretation will be available for the entire symposium. View the full programme

View details View details
two technicians working with a microscope in a lab

19 May 2022

Research priorities for an HIV cure: IAS Global Scientific Strategy

An HIV cure is a high priority for people living with HIV and an essential tool for the HIV response; a curative intervention could overcome the limitations of antiretroviral therapy (ART), limit new HIV transmissions, reduce stigma and discrimination, and provide a sustainable financial solution for epidemic control. IAS – the International AIDS Society – convened a 68-member International Scientific Working Group to develop the third Global Scientific Strategy, published in Nature Medicine in December 2021. Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021 is a comprehensive roadmap featuring the most pressing gaps in HIV cure research and research priorities to guide the field toward a widely accessible, acceptable and affordable cure. This webinar will take participants through the eight key focal areas of the strategy and how to apply the recommendations to their work.

View details View details